This reparable strategy is based on such concepts that the failing myocyte accompanied with intrinsic defects in structure and function could be improved biologically .
And this is due to mutations in the TSC1 or TSC2 tumor suppressor genes, genes that usually suppress tumor growth, therefore a mutation leads to myocyte overgrowth.